202 related articles for article (PubMed ID: 31287801)
1. A novel individualized drug repositioning approach for predicting personalized candidate drugs for type 1 diabetes mellitus.
Zheng H
Stat Appl Genet Mol Biol; 2019 Jul; 18(5):. PubMed ID: 31287801
[TBL] [Abstract][Full Text] [Related]
2. Individualized Drug Repositioning For Rheumatoid Arthritis Using Weighted Kolmogorov-Smirnov Algorithm.
Hu RY; Tian XB; Li B; Luo R; Zhang B; Zhao JM
Pharmgenomics Pers Med; 2019; 12():369-375. PubMed ID: 31849513
[TBL] [Abstract][Full Text] [Related]
3. MD-Miner: a network-based approach for personalized drug repositioning.
Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
[TBL] [Abstract][Full Text] [Related]
4. Drug repositioning for diabetes based on 'omics' data mining.
Zhang M; Luo H; Xi Z; Rogaeva E
PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Drugs to Target the Diabetes Epidemic.
Turner N; Zeng XY; Osborne B; Rogers S; Ye JM
Trends Pharmacol Sci; 2016 May; 37(5):379-389. PubMed ID: 26900045
[TBL] [Abstract][Full Text] [Related]
6. PISTON: Predicting drug indications and side effects using topic modeling and natural language processing.
Jang G; Lee T; Hwang S; Park C; Ahn J; Seo S; Hwang Y; Yoon Y
J Biomed Inform; 2018 Nov; 87():96-107. PubMed ID: 30268842
[TBL] [Abstract][Full Text] [Related]
7. NetPro: Neighborhood Interaction-Based Drug Repositioning via Label Propagation.
Huang Y; Bin Y; Zeng P; Lan W; Zhong C
IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(3):2159-2169. PubMed ID: 37018341
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome Signature Reversion as a Method to Reposition Drugs Against Cancer for Precision Oncology.
Koudijs KKM; Terwisscha van Scheltinga AGT; Böhringer S; Schimmel KJM; Guchelaar HJ
Cancer J; 2019; 25(2):116-120. PubMed ID: 30896533
[TBL] [Abstract][Full Text] [Related]
9. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
Liu H; Song Y; Guan J; Luo L; Zhuang Z
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
[TBL] [Abstract][Full Text] [Related]
10. BiRWDDA: A Novel Drug Repositioning Method Based on Multisimilarity Fusion.
Yan CK; Wang WX; Zhang G; Wang JL; Patel A
J Comput Biol; 2019 Nov; 26(11):1230-1242. PubMed ID: 31140857
[No Abstract] [Full Text] [Related]
11. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
[TBL] [Abstract][Full Text] [Related]
12. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
13. Personalised drug repositioning for Clear Cell Renal Cell Carcinoma using gene expression.
Koudijs KKM; Terwisscha van Scheltinga AGT; Böhringer S; Schimmel KJM; Guchelaar HJ
Sci Rep; 2018 Mar; 8(1):5250. PubMed ID: 29588458
[TBL] [Abstract][Full Text] [Related]
14. Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario.
Katare PB; Banerjee SK
Curr Top Med Chem; 2016; 16(19):2189-200. PubMed ID: 26881721
[TBL] [Abstract][Full Text] [Related]
15. Adult-onset autoimmune diabetes: current knowledge and implications for management.
Buzzetti R; Zampetti S; Maddaloni E
Nat Rev Endocrinol; 2017 Nov; 13(11):674-686. PubMed ID: 28885622
[TBL] [Abstract][Full Text] [Related]
16. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
18. Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.
Mikov M; Đanić M; Pavlović N; Stanimirov B; Goločorbin-Kon S; Stankov K; Al-Salami H
Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):269-280. PubMed ID: 29039071
[TBL] [Abstract][Full Text] [Related]
19. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Cheng F; Hong H; Yang S; Wei Y
Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
